Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.

Hoxha A, Favaro M, Calligaro A, Del Ross T, Ruffatti AT, Infantolino C, Tonello M, Mattia E, Ruffatti A.

Thromb Haemost. 2019 Oct 21. doi: 10.1055/s-0039-1697665. [Epub ahead of print]

PMID:
31634958
2.

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Hoxha A, Tincani A, Nalli C, Marozio L, Maina A, Espinosa G, Ríos-Garcés R, Cervera R, Carolis S, Monteleone G, Latino O, Udry S, LLurba E, Garrido-Gimenez C, Trespidi L, Gerosa M, Chighizola CB, Rovere-Querini P, Canti V, Mayer-Pickel K, Tabacco S, Arnau A, Trapé J, Ruiz-Hidalgo D, Sos L, Farran-Codina I.

Rheumatology (Oxford). 2019 Oct 3. pii: kez419. doi: 10.1093/rheumatology/kez419. [Epub ahead of print]

PMID:
31580459
3.

Therapeutic apheresis during pregnancy: A single center experience.

Colpo A, Marson P, Pavanello F, Tison T, Gervasi MT, Zambon A, Ruffatti A, De Silvestro G, Hoxha A.

Transfus Apher Sci. 2019 Sep 5. pii: S1473-0502(19)30185-5. doi: 10.1016/j.transci.2019.07.009. [Epub ahead of print]

PMID:
31522920
4.

Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome.

Scambi C, Ugolini S, Tonello M, Bortolami O, De Franceschi L, Castagna A, Lotti V, Corbella M, Raffaelli R, Caramaschi P, Mattia E, Biasi D, Ruffatti A.

Am J Reprod Immunol. 2019 Dec;82(6):e13185. doi: 10.1111/aji.13185. Epub 2019 Sep 16.

PMID:
31479579
5.

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.

Lazzaroni MG, Fredi M, Andreoli L, Chighizola CB, Del Ross T, Gerosa M, Kuzenko A, Raimondo MG, Lojacono A, Ramazzotto F, Zatti S, Trespidi L, Meroni PL, Pengo V, Ruffatti A, Tincani A.

Front Immunol. 2019 Aug 14;10:1948. doi: 10.3389/fimmu.2019.01948. eCollection 2019.

6.

An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases.

Reggia R, Andreoli L, Sebbar H, Canti V, Ceccarelli F, Favaro M, Hoxha A, Inversetti A, Larosa M, Ramoni V, Caporali R, Conti F, Doria A, Montecucco C, Rovere-Querini P, Ruffatti A, Valesini G, Zatti S, Fallo L, Lojacono A, Tincani A.

Rheumatol Adv Pract. 2019 Feb 22;3(1):rkz005. doi: 10.1093/rap/rkz005. eCollection 2019.

7.

IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.

Tonello M, Mattia E, Favaro M, Del Ross T, Calligaro A, Salvan E, Hoxha A, Fedrigo M, Ruffatti A.

Thromb Res. 2019 May;177:157-160. doi: 10.1016/j.thromres.2019.03.006. Epub 2019 Mar 8.

PMID:
30903876
8.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

9.

Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab.

Ruffatti A, Tarzia V, Fedrigo M, Calligaro A, Favaro M, Macor P, Tison T, Cucchini U, Cosmi E, Tedesco F, Angelini A, Gerosa G.

Autoimmun Rev. 2019 May;18(5):561-563. doi: 10.1016/j.autrev.2019.03.015. Epub 2019 Mar 4. No abstract available.

PMID:
30844561
10.

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-Garcés R, De Carolis S, Latino O, LLurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-Hidalgo D, Trapé J, Sos L, Stoppani C, Martí-Cañamares A, Farran-Codina I; EUROAPS Study Group.

Autoimmun Rev. 2019 Apr;18(4):406-414. doi: 10.1016/j.autrev.2018.12.006. Epub 2019 Feb 15.

PMID:
30772493
11.

Management of pregnant women with antiphospholipid antibodies.

Ruffatti A, Favaro M, Calligaro A, Zambon A, Del Ross T.

Expert Rev Clin Immunol. 2019 Apr;15(4):347-358. doi: 10.1080/1744666X.2019.1565995. Epub 2019 Jan 11.

PMID:
30616398
12.

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases.

Andreoli L, Lazzaroni MG, Carini C, Dall'Ara F, Nalli C, Reggia R, Rodrigues M, Benigno C, Baldissera E, Bartoloni-Bocci E, Basta F, Bellisai F, Bortoluzzi A, Campochiaro C, Cantatore FP, Caporali R, Ceribelli A, Chighizola CB, Conigliaro P, Corrado A, Cutolo M, D'Angelo S, De Stefani E, Doria A, Favaro M, Fischetti C, Foti R, Gabrielli A, Generali E, Gerli R, Gerosa M, Larosa M, Maier A, Malavolta N, Meroni M, Meroni PL, Montecucco C, Mosca M, Padovan M, Paolazzi G, Pazzola G, Peccatori S, Perricone R, Pettiti G, Picerno V, Prevete I, Ramoni V, Romeo N, Ruffatti A, Salvarani C, Sebastiani GD, Selmi C, Serale F, Sinigaglia L, Tani C, Trevisani M, Vadacca M, Valentini E, Valesini G, Visalli E, Vivaldelli E, Zuliani L, Tincani A.

Joint Bone Spine. 2019 Jul;86(4):475-481. doi: 10.1016/j.jbspin.2018.12.002. Epub 2018 Dec 21.

PMID:
30579917
13.

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns.

Pengo V, Del Ross T, Ruffatti A, Bison E, Cattini MG, Pontara E, Testa S, Legnani C, Pozzi N, Peterle D, Acquasaliente L, De Filippis V, Denas G.

Thromb Res. 2018 Dec;172:172-178. doi: 10.1016/j.thromres.2018.11.003. Epub 2018 Nov 9.

PMID:
30466070
14.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
15.

Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.

Ruffatti A, De Silvestro G, Marson P, Tonello M, Calligaro A, Favaro M, Del Ross T, Hoxha A, Mattia E, Pengo V.

J Autoimmun. 2018 Sep;93:124-130. doi: 10.1016/j.jaut.2018.07.001. Epub 2018 Jul 7.

PMID:
30146007
16.

Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.

Canti V, Del Rosso S, Tonello M, Lucianò R, Hoxha A, Coletto LA, Vaglio Tessitore I, Rosa S, Manfredi AA, Castiglioni MT, Ruffatti A, Rovere-Querini P.

J Rheumatol. 2018 Aug;45(9):1263-1272. doi: 10.3899/jrheum.170751. Epub 2018 Jul 15.

PMID:
30008452
17.

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A.

Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12.

PMID:
30002145
18.

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.

Tonello M, Mattia E, Del Ross T, Favaro M, Calligaro A, Hoxha A, Bison E, Pengo V, Ruffatti A.

Clin Chim Acta. 2018 Oct;485:74-78. doi: 10.1016/j.cca.2018.06.037. Epub 2018 Jun 25.

PMID:
29953850
19.

Clinical and laboratory characteristics of isolated lupus anticoagulants.

Mattia E, Tonello M, Del Ross T, Zerbinati P, Campello E, Simioni P, Ruffatti A.

Thromb Res. 2018 May;165:51-53. doi: 10.1016/j.thromres.2018.03.008. Epub 2018 Mar 13. No abstract available.

PMID:
29567587
20.

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau N, Morel N, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Khamashta MA.

Thromb Haemost. 2018 Apr;118(4):639-646. doi: 10.1055/s-0038-1632388. Epub 2018 Feb 28.

21.

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.

Chighizola CB, Pregnolato F, Andreoli L, Bodio C, Cesana L, Comerio C, Gerosa M, Grossi C, Kumar R, Lazzaroni MG, Mahler M, Mattia E, Nalli C, Norman GL, Raimondo MG, Ruffatti A, Tonello M, Trespidi L, Tincani A, Borghi MO, Meroni PL.

J Autoimmun. 2018 Jun;90:76-83. doi: 10.1016/j.jaut.2018.02.002. Epub 2018 Feb 14.

PMID:
29454510
22.

European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block.

Kyriakidis NC, Kockum I, Julkunen H, Hoxha A, Salomonsson S, Meneghel L, Ebbing C; Swedish Congenital Heart Block Study Group, Dilthey A, Eronen M, De Carolis S, Kiserud T, Ruffatti A, Kere J, Meisgen S, Wahren-Herlenius M.

Ann Rheum Dis. 2018 Sep;77(9):1381-1382. doi: 10.1136/annrheumdis-2018-212953. Epub 2018 Feb 16. No abstract available.

PMID:
29453219
23.

The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.

Chighizola CB, Andreoli L, Gerosa M, Tincani A, Ruffatti A, Meroni PL.

J Autoimmun. 2018 Jun;90:1-27. doi: 10.1016/j.jaut.2018.02.003. Epub 2018 Feb 13. Review.

PMID:
29449131
24.

Thrombocytopenia in high-risk patients with antiphospholipid syndrome.

Pontara E, Banzato A, Bison E, Cattini MG, Baroni G, Denas G, Calligaro A, Marson P, Tison T, Ruffatti A, Pengo V.

J Thromb Haemost. 2018 Mar;16(3):529-532. doi: 10.1111/jth.13947. Epub 2018 Jan 25.

PMID:
29316193
25.

Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study.

Campello E, Radu CM, Tonello M, Kuzenko A, Bulato C, Hoxha A, Mattia E, Spiezia L, Ruffatti A, Simioni P.

Scand J Rheumatol. 2018 Nov;47(6):501-504. doi: 10.1080/03009742.2017.1372518. Epub 2018 Jan 8. No abstract available.

PMID:
29308695
26.

Detection of autoantibodies to the p200-epitope of SSA/Ro52 antigen. A comparison of two laboratory assays.

Mattia E, Hoxha A, Tonello M, Favaro M, Del Ross T, Calligaro A, Ghirardello A, Ruffatti A.

Clin Chem Lab Med. 2018 May 24;56(6):927-932. doi: 10.1515/cclm-2017-0704.

PMID:
29303768
27.

Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, LLurba E, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Espinosa G, de Carolis S, Rovere-Querini P, Lundelin K, Picardo E, Mekinian A; EUROAPS Study Group.

Med Clin (Barc). 2018 Sep 21;151(6):215-222. doi: 10.1016/j.medcli.2017.11.017. Epub 2017 Dec 20. English, Spanish.

PMID:
29274674
28.

Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Ainsworth HC, Marion MC, Bertero T, Brucato A, Cimaz R, Costedoat-Chalumeau N, Fredi M, Gaffney P, Kelly J, Levesque K, Maltret A, Morel N, Ramoni V, Ruffatti A, Langefeld CD, Buyon JP, Clancy RM.

Arthritis Rheumatol. 2017 Nov;69(11):2170-2174. doi: 10.1002/art.40228. Epub 2017 Oct 17.

29.

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.

Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2017 Sep;16(9):911-924. doi: 10.1016/j.autrev.2017.07.012. Epub 2017 Jul 11. Review.

PMID:
28705780
30.

Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.

Taraborelli M, Reggia R, Dall'Ara F, Fredi M, Andreoli L, Gerosa M, Hoxha A, Massaro L, Tonello M, Costedoat-Chalumeau N, Cacoub P, Franceschini F, Meroni PL, Piette JC, Ruffatti A, Valesini G, Harris EN, Tincani A.

J Rheumatol. 2017 Aug;44(8):1165-1172. doi: 10.3899/jrheum.161364. Epub 2017 Jun 1.

PMID:
28572466
31.

Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.

Mekinian A, Alijotas-Reig J, Carrat F, Costedoat-Chalumeau N, Ruffatti A, Lazzaroni MG, Tabacco S, Maina A, Masseau A, Morel N, Esteve-Valverde EE, Ferrer-Oliveras R, Andreoli L, De Carolis S, Josselin-Mahr L, Abisror N, Nicaise-Roland P, Tincani A, Fain O; on the behalf of the SNFMI and the European Forum on Antiphospholipid Antibodies.

Autoimmun Rev. 2017 Jul;16(7):730-734. doi: 10.1016/j.autrev.2017.05.006. Epub 2017 May 4. Review.

PMID:
28478081
32.

Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.

Tonello M, Hoxha A, Mattia E, Zambon A, Visentin S, Cerutti A, Ghirardello A, Milanesi O, Ruffatti A.

Clin Rheumatol. 2017 May;36(5):1155-1160. doi: 10.1007/s10067-017-3572-2. Epub 2017 Feb 15.

PMID:
28204891
33.

Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.

Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, Rizzo N, Facchinetti F, Dall'Asta A, Visentin S, Sarno L, Xodo S, Bernabini D, Monari F, Roman A, Eke AC, Hoxha A, Ruffatti A, Schuit E, Martinelli P; PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group.

Am J Obstet Gynecol. 2017 May;216(5):525.e1-525.e12. doi: 10.1016/j.ajog.2017.01.026. Epub 2017 Jan 30.

PMID:
28153662
34.

Detection of lupus anticoagulant in the era of direct oral anticoagulants.

Hoxha A, Banzato A, Ruffatti A, Pengo V.

Autoimmun Rev. 2017 Feb;16(2):173-178. doi: 10.1016/j.autrev.2016.12.010. Epub 2016 Dec 15. Review.

PMID:
27988438
35.
36.

Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.

Hoxha A, Mattia E, Tonello M, Grava C, Pengo V, Ruffatti A.

Clin Chem Lab Med. 2017 May 1;55(6):890-898. doi: 10.1515/cclm-2016-0638.

PMID:
27816952
37.

APS - Diagnostics and challenges for the future.

Pengo V, Bison E, Zoppellaro G, Padayattil Jose S, Denas G, Hoxha A, Ruffatti A, Banzato A.

Autoimmun Rev. 2016 Nov;15(11):1031-1033. doi: 10.1016/j.autrev.2016.07.028. Epub 2016 Jul 31. Review.

PMID:
27486689
38.

Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.

Hoxha A, Ruffatti A, Ambrosi A, Ottosson V, Hedlund M, Ottosson L, Anandapadamanaban M, Sunnerhagen M, Sonesson SE, Wahren-Herlenius M.

Clin Exp Immunol. 2016 Dec;186(3):284-291. doi: 10.1111/cei.12854. Epub 2016 Sep 13.

39.

Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Nuri E, Taraborelli M, Andreoli L, Tonello M, Gerosa M, Calligaro A, Argolini LM, Kumar R, Pengo V, Meroni PL, Ruffatti A, Tincani A.

Immunol Res. 2017 Feb;65(1):17-24. doi: 10.1007/s12026-016-8812-z.

PMID:
27406736
40.

Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort.

Alijotas-Reig J, Ferrer-Oliveras R, Esteve-Valverde E, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Espinosa G, Coloma E, de Carolis S, Rovere-Querini P, Canti V, Picardo E, Fredi M, Mekinian A; EUROAPS Study Group.

Am J Reprod Immunol. 2016 Aug;76(2):164-71. doi: 10.1111/aji.12534.

PMID:
27401589
41.

Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study.

Ruffatti A, Cerutti A, Favaro M, Del Ross T, Calligaro A, Hoxha A, Marson P, Leoni L, Milanesi O.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):706-13. Epub 2016 Jun 22.

PMID:
27385463
42.

Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study.

Hoxha A, Calligaro A, Di Poi E, Peccatori S, Favaro M, Del Ross T, Ramonda R, Grava C, Raffeiner B, Ravagni P, De Vita S, Ruffatti A.

Joint Bone Spine. 2017 Mar;84(2):169-173. doi: 10.1016/j.jbspin.2016.03.014. Epub 2016 Jun 22.

PMID:
27344079
43.

Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U, Banzato A, Pengo V.

Clin Rev Allergy Immunol. 2017 Aug;53(1):28-39. doi: 10.1007/s12016-016-8571-6. Review.

PMID:
27342460
44.

Laboratory testing for antiphospholipid syndrome.

Pengo V, Banzato A, Bison E, Denas G, Zoppellaro G, Bracco A, Padayattil Jose S, Hoxha A, Ruffatti A.

Int J Lab Hematol. 2016 May;38 Suppl 1:27-31. doi: 10.1111/ijlh.12507. Epub 2016 May 9. Review.

PMID:
27161602
45.

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study.

Ruffatti A, Favaro M, Hoxha A, Zambon A, Marson P, Del Ross T, Calligaro A, Tonello M, Nardelli GB.

J Reprod Immunol. 2016 Jun;115:14-9. doi: 10.1016/j.jri.2016.03.004. Epub 2016 Mar 29.

PMID:
27088752
46.

Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients.

Tonello M, Ruffatti A, Favaro M, Tison T, Del Ross T, Calligaro A, Hoxha A, Mattia E, Punzi L.

Lupus Sci Med. 2016 Mar 24;3(1):e000129. doi: 10.1136/lupus-2015-000129. eCollection 2016.

47.

The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study.

Hoxha A, Calligaro A, Tonello M, Ramonda R, Carletto A, Paolazzi G, Bortolotti R, Del Ross T, Grava C, Boaretto M, Favaro M, Teghil V, Ruffatti A, Punzi L.

Joint Bone Spine. 2016 Mar;83(2):167-71. doi: 10.1016/j.jbspin.2015.04.020. Epub 2015 Dec 29.

PMID:
26750762
48.

Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block.

Ruffatti A, Favaro M, Brucato A, Ramoni V, Facchinetti M, Tonello M, Del Ross T, Calligaro A, Hoxha A, Grava C, De Silvestro G.

Transfus Apher Sci. 2015 Dec;53(3):269-78. doi: 10.1016/j.transci.2015.11.006. Epub 2015 Nov 25. Review.

PMID:
26626966
49.

Diagnosis and therapy of antiphospholipid syndrome. Author's reply.

Pengo V, Hoxha A, Ruffatti A.

Pol Arch Med Wewn. 2015;125(10):785-6. No abstract available.

50.

The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.

Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calligaro A, Favaro M, Facchinetti M, Hoxha A, Punzi L.

Thromb Res. 2015 Nov;136(5):883-6. doi: 10.1016/j.thromres.2015.08.019. Epub 2015 Sep 5.

PMID:
26410418

Supplemental Content

Loading ...
Support Center